Sabra Health Care REIT, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 93.09 million compared to USD 84.21 million a year ago. Revenue was USD 161.63 million compared to USD 140.76 million a year ago. Net loss was USD 15.1 million compared to USD 50.06 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.22 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to USD 0.22 a year ago.
For the nine months, sales was USD 283.23 million compared to USD 297.27 million a year ago. Revenue was USD 484.12 million compared to USD 459.83 million a year ago. Net loss was USD 3.4 million compared to net income of USD 7.34 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to diluted earnings per share from continuing operations of USD 0.03 a year ago.